In Israel, Evogene has announced its financial results for Q4 and 2014. The company announced that Evofuel continues to make progress toward commercializing its propriety castor seeds in 2016 with key achievements in strengthening its agronomic offering and commercial reach in Brazil.
Ofer Haviv, Evogene’s President and CEO, stated: “This past year was a year of significant progress and achievements as we continue to establish Evogene as a recognized innovation engine for novel product candidates in multiple agriculture based industries.”
“In the area of yield and abiotic stress, the most mature of our four current areas of activity, we have expanded our capabilities to include new computational systems designed to optimize desired trait efficacy and accelerate product development efforts for the genes we discover, as demonstrated in the incorporation of these new capabilities into our collaboration with Monsanto.”
“In the area of biotic stress, during 2014 we announced our entry into the field of insect resistance with an initial projected investment of $10 million in support of our activities in this significant market area. As a first step, we enhanced our computational discovery capabilities and expanded our supporting infrastructure with dedicated R&D facilities in Israel, accompanied by a larger US-based facility to be operational by end 2015.”
More on the story.
